Evidence map›Paper›PMID 40011282›Full record

ArticleCardiovascular and interventional radiology2025

Long-term Outcomes of Endovascular Versus Medical Treatment for Isolated Superior Mesenteric Artery Dissection: A 10-Year Retrospective Study.

Bing Wang, Jun Pan, Yiting Xu, Xuxian Qiu, Zhenwei Ding, Donlin Li, Hongkun Zhang, Chenyang Qiu, Ziheng Wu

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05171842 (Safety and Efficacy of Endovascular Treatment in Patients With Spontaneous Isolated Superior Mesenteric Artery Dissection), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05171842 completednot on this map

Safety and Efficacy of Endovascular Treatment in Patients With Spontaneous Isolated Superior Mesenteric Artery Dissection: a Multicenter, Prospective Single-arm Observational Study

TypeobservationalSponsorFirst Affiliated Hospital of Zhejiang UniversityRan2021 to 2025Enrolled136ConditionsDissection of the Superior Mesenteric ArteryArmsObserve the prognosis after stent implantation
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bing Wang *Department of Vascular Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79# Qingchun Rd, Hangzhou, 310003, China.
Jun Pan *Department of Vascular Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79# Qingchun Rd, Hangzhou, 310003, China.
Yiting Xu *Department of Vascular Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79# Qingchun Rd, Hangzhou, 310003, China.
Xuxian QiuDepartment of Vascular Nursing, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Zhenwei DingDepartment of Surgery, Affiliated Xiaoshan Hospital, Hangzhou Normal University, No.728 North Yucai Road, Hangzhou, China.
Donlin LiDepartment of Vascular Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79# Qingchun Rd, Hangzhou, 310003, China.
Hongkun ZhangDepartment of Vascular Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79# Qingchun Rd, Hangzhou, 310003, China.
Chenyang QiuDepartment of Vascular Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79# Qingchun Rd, Hangzhou, 310003, China. docqiu@zju.edu.cn.
Ziheng WuDepartment of Vascular Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79# Qingchun Rd, Hangzhou, 310003, China. wuziheng@zju.edu.cn.ORCID http://orcid.org/0000-0001-8960-9733

Funding

Health and medical technology Program of Zhejiang Province 2023KY687
6 · The paper itself

Abstract

purposeIsolated superior mesenteric artery dissection (IMAD) is increasing in prevalence. Both endovascular and medical treatments are frequently used, but based on studies with relatively small sample sizes and limited follow-up. This article aims to compare the long-term outcomes of medical treatment versus endovascular treatment for isolated superior mesenteric artery dissection. MATERIALS AND

methodsPatients who were treated for IMAD at our institution between June 2009 and March 2019 were retrospectively investigated. The primary outcomes were freedom from adverse events and the complete remodeling rate. Propensity score matching (PSM) was used to align baseline data, ensuring comparability between the two groups.

resultsThe study cohort comprises 226 patients with IMAD. The mean follow-up duration was 74.9 ± 28.3 months. One hundred and ninety-one patients (84.5%) received endovascular treatment, and 35 (15.5%) were treated medically. The freedom from adverse event rate was 91.8% in the endovascular group and 79.6% in the medical group at 60 months (p < 0.05) and 87.6% and 74.6%, at 120 months (p < 0.05). The complete remodeling rate was 69.3% in the endovascular group and 29.0% in the medical group (p < 0.01) at 60 months and 70.8% and 37.8%, respectively, at 120 months (p < 0.01). After propensity score matching, the freedom from adverse event rate was 91.9% versus 85.6% (p < 0.05) at 60 months and 87.8% versus 78.6% (p < 0.05) at 120 months. The complete remodeling rate was 69.8% versus 43.0% (p < 0.01) at 60 months and 71.2% in the endovascular group versus 43.0%.

conclusionThe freedom from adverse event and complete remodeling rates were higher in patients with IMAD who received endovascular treatment than in those who were treated medically during long-term follow-up. LEVEL OF EVIDENCE: Level 3, non-randomized controlled cohort/follow-up study.

Indexed as

Aortic DissectionEndovascular ProceduresMesenteric Artery, SuperiorAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPropensity ScoreRetrospective StudiesTreatment OutcomeComplete remodelingEndovascular treatmentIsolated superior mesenteric artery dissectionMedical treatmentReintervention

Identifiers

PMID40011282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.